Contents

Current Angiogenesis (Discontinued), Volume 1 - Number 2

Histidine Rich Glycoprotein, an Endogenous Regulator of Macrophage and Endothelial Biology

, 1(2): 81 - 87

Lena Claesson-Welsh and Sonia Tugues


DOI: 10.2174/2211552811201020081




Regulation of Tumor Angiogenesis by the Immune System

, 1(2): 88 - 97

Keri Schadler Stewart and Sandra W. Ryeom


DOI: 10.2174/2211552811201020088




To Enhance or to Inhibit Integrin Function in Angiogenesis, that is the Question

, 1(2): 98 - 104

Roy Zent and Ambra Pozzi


DOI: 10.2174/2211552811201020098




Neovascular Age-related Macular Degeneration: Past, Present, and Future

, 1(2): 105 - 114

Leo A. Kim and Patricia A. D’Amore


DOI: 10.2174/2211552811201020105




Biomarkers of Angiogenesis and their Role in Patient Selection for Antiangiogenic Therapy

, 1(2): 115 - 124

Steven Pirie-Shepherd


DOI: 10.2174/2211552811201020115




Neuropilin Signalling in Vascular Development and Pathology

, 1(2): 125 - 132

Alessandro Fantin, Alice Plein and Christiana Ruhrberg


DOI: 10.2174/2211552811201020125




Vascular Mimicry: Concepts and Implications for Anti-Angiogenic Therapy

, 1(2): 133 - 138

James M. Dunleavey and Andrew C. Dudley


DOI: 10.2174/2211552811201020133




Mechanisms of Angiogenesis: Perspectives from Antiangiogenic Tumor Therapies

, 1(2): 139 - 147

Jeffrey J. Rice, Par Gerwins and Witold W. Kilarski


DOI: 10.2174/2211552811201020139




Anti-tumoral Properties of Endogenous Angiogenesis Inhibitors: A Case for Continued TIMP-2 Preclinical Development

, 1(2): 148 - 156

William G. Stetler-Stevenson, Dimitra Bourboulia, Liliana Guedez and Sandra Jensen-Taubman


DOI: 10.2174/2211552811201020148




Angiogenesis Inhibitors and Radiation in Multimodality Cancer Therapy: Preclinical and Clinical Studies

, 1(2): 157 - 167

Jennifer Vogel and Kevin Camphausen


DOI: 10.2174/2211552811201020157




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science